UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Positive Regulatory Developments for the U.S. Ag Tech Industry

2019 may prove to be propitious in terms of meaningful improvements to the regulatory strictures facing agricultural biotech and biologically based products.

In a move that will hopefully lead to positive changes in the regulatory situation facing ag biotech products, on June 11, 2019, President Trump signed an Executive Order directing the heads of the U.S. Department of Agriculture (USDA), Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) to take specific steps to streamline and improve the regulatory processes applicable to the products of agricultural biotechnology.

Read More

Probiotics Congress: Europe Presentation Slides

Following the Probiotics Congress: Europe, we have made the following presentation slides from Jean-Francois Brugère, Grégory Lambert, Bruno Pot and Koen Venema available.

Read More

A global perspective on the developments in biotech regulations

The ECJ ruling on GMOs has raised pertinent issues. How will it impact on current and future research? What are the optimum routes to progressing plant research?

In light of the ruling, it was a good time to welcome experts in policy and regulatory affairs to the recent 7th Plant Genomics & Gene Editing Congress: Europe to explore these issues. We’re lucky to be able to share this presentation from the event for those that weren’t able to make it. Watch it here.

Read More

The Skin Microbiome & Cosmeceuticals Congress presentation slides

Following the Skin Microbiome & Cosmeceuticals Congress: Europe, we have made the following presentation slides from Richard Andrews, Ingmar Claes, Marie Drago & Maya Ivanjesku available.

Read More

Assessment of the European Court of Justice ruling on gene editing for crop improvement

Anyone involved in the field of agriculture and biotechnology would have been unable to ignore the ECJ ruling on case C-528/16 in July 2018. The ruling confirmed that all plants obtained by any form of mutagenesis are GMOs as defined by Directive (EC) no. 2001/18 and rejected an annulment of mutagenesis exemption (Annex IB of Directive 2001/18. With significant ramifications across the industry, the ECJ stance on gene edited crops and GMOs was a major focus of the 7th Plant Genomics & Gene Editing Congress: Europe.

Read More

Strategic screening enables effective biomarker discovery

During my eight years at the Max Planck Institute for Molecular Genetics in Berlin, I led a protein technologies group. We developed a protein expression library, and then high-content protein arrays. In total, we made arrays with 10,000 different human proteins.

Read More

Flow Cytometry: A powerful tool in drug discovery

Flow cytometry is a powerful tool in drug discovery because it provides a way to understand the drug’s mechanism of action. In order to stratify a better target for patients, you often need to know where the drug is working, and what kind of pathway it is operating along.

Read More

A novel fungal endophyte confers fitness benefits to crops

Researchers at the Polytechnic University of Madrid (UPM) in Spain, in collaboration with scientists with PlantResponse Biotech, S.L., are conducting research on a novel fungal endophyte that confers crop fitness benefits, particularly in alkaline soils.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive